Type 1 autoimmune hepatitis in Taiwan: Diagnosis using the revised criteria of the International Autoimmune Hepatitis Group

Digestive Diseases and Sciences

Volumn 51, Issue 11, 2006, Pages 1978-1984

  Koay, Lok Beng ^a   Lin, Ching Yih ^a   Tsai, Sun Lung ^a   Lee, Chuan ^a   Lin, Ching Nan ^a   Sheu, Ming Juen ^a   Kuo, Hsing Tao ^a   Sun, Chi Shu ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Antinuclear antibodies; Autoimmune hepatitis; Autoimmune hepatitis type 1; Liver cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLOBULIN; PREDNISOLONE; STEROID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANOREXIA; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; FATIGUE; FEMALE; FISHER EXACT TEST; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; JAUNDICE; KAPLAN MEIER METHOD; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RANK SUM TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STEROID THERAPY; SURVIVAL RATE; TAIWAN; TREATMENT RESPONSE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GENES, MHC CLASS I; GENES, MHC CLASS II; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SEX DISTRIBUTION; TAIWAN;

EID: 33751525775     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-9068-y     Document Type: Article

References (38)

1. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, Cooksley WGE, Czaja AJ, Desmet VJ, Donaldson PT, Eddleston ALWF, Fainboim L, Heathcote J, Homberg J-C, Hoofnagle JH, Kakumu S, Krawitt EL, Mackay IR, MacSween RNM, Maddrey WC, Manns MP, McFarlane IG, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Nakanuma Y, Nishioka M, Penner E, Porta G, Portmann BC, Reed WD, Rodes J, Schalm SW, Scheuer PJ, Schrumpf E, Seki T, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929-938
2. International Working Party (1995) Terminology of chronic hepatitis. Am J Gastroenterol 90:181-189
3. Czaja AJ (2005) Current concepts in autoimmune hepatitis. Ann Hepatol 4(1):6-24
4. Boberg KM, Adland E, Jahnsen J, Raknerud N, Stiris M, Bell H (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33:99-103
5. Toda G, Zeniya M, Watanabe F, Imawari M, Kiyosawa K, Nishioka M, Tsuji T, Omata M (1997) Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 26:1207-1212
6. Lee YM, Teo EK, NG TM, Khor C, Fock KM (2001) Autoimmune hepatitis in Singapore: A rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 16:1384-138
7. Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK (2001) Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol 16:1144-1148
8. Koay LB, Sun CS, Hsu SI, Chen JJ, Lin CY (2001) Type 1 autoimmune hepatitis micmicking crytogenic hepatitis. Gastroenterol J Taiwan 18:132-138
9. Huang HC, Huang YS, Wu JC, Tsay SH, Huo TI, Wang YJ, Lo JC, Chen CY, Li CP, Chang FY, Lee SD (2002) Characteristics of autoimmune hepatitis in Taiwan: the 11 year experiences of a medical center. Chinese Med J (Taipei) 65:563-569
10. Qiu DK, Ma X (2003) Relationship between human leukocyte antigen-DRBI and autoimmune hepatitis type 1 in Chinese patients. J. Gastroenterol Hepatol 18:63-67
11. Johnson PJ, Mcfarlane IG (1993) Meeting report: International Autoimmune Hepatitis Group. Hepatology 18:998-1005
12. Czaja AJ, Carpenter HA (1996) Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 41:305-314
13. Nishioka M, Morshed SA, McFarlane IG (1998) Geographical variation in the frequency and characteristics of autoimmune liver diseases. In: Krawitt EL, Wiesner RH, Nishioka M (eds) Autoimmune liver diseases, 2nd ed. Elsevier, Amsterdam, pp 413-424
14. Boberg KM (2002) Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 6:347-359
15. Sherlock S, Dooley J (1993) Chronic autoimmune hepatitis. In: Diseases of the liver and biliary system. Blackwell Science, Oxford, pp 299-306
16. Parker DR, Kingham JGC (1997) Type 1 autoimmune hepatitis is primarily a disease of later life. Q J Med 90:289-296
17. Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani E, Chiodo F, Bianchi FB (2004) Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. Q J Med 97(7):407-417
18. Krawitt EL (1996) Autoimmune hepatitis. N Eng J Med 334:897-903
19. Czaja AJ, Mann MP (1995) The validity and importance of subtypes of autoimmune hepatitis: a point of view. Am J Gastroenterol 90:1206-1211
20. Homberg J-C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, Darnis F, Levy V-G, Grippon P, Opolon P, Bernuau J, Benhamou J-P, Alagille D (1987) Chronic active hepatitis associated with anti-liver/kidney microsome type 1: a second type of "autoimmune" hepatitis. Hepatology 7:1333-1339
21. Manns MP (1997) Recent developments in autoimmune liver diseases. J Gastroenterol Hepatol 12(Suppl):s256-s271
22. Whittingham S, Mackay IR, Irwin J (1966) Autoimmune hepatitis: immunofluorescence reactions with cytoplasm of smooth muscle and glomerular cells. Lancet 1:1333-1335
23. Czja AJ, Cassani F, Cataleta M (1966) Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068-1073
24. Mcfarlane IG (1998) The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42:599-602
25. Czja AJ, Donaldson PT, Lohse AW (2002) Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis. Am J Gastroenterol 97:413-419
26. Targan SR, Landers C, Vidrich A (1995) High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology 108:1159-1166
27. Obermayer-Straub P, Strassburg CP, Manns MP Autoimmune hepatitis. J Hepatol 32(Suppl 1):181-197
28. Czaja AJ, Doherty DG, Donalson PT (2002) Genetic bases of autoimmune hepatitis. Dig Dis Sci 47:2139-2150
29. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R (1991) Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13:701-706
30. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB (1993) Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105:1502-1507
31. Seki T, Kiyosawa K, Inoko H, Ota M (1990) Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology 12:1300-1304
32. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, William R (1997) Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25:317-323
33. Czaja AJ (1996) Diagnosis and therapy of autoimmune liver disease. Med Clin North Am 80:973-994
34. Roberts SK, Therneau TM, Czaja AJ (1996) Prognosis of histological cirrhosis in type | autoimmune hepatitis. Gastroenterology 110:848-857
35. Omagari K, Kinoshita H, Kato Y, Nakata K, Kanematsu T, Kusumoto Y, Mori I (1999) Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 34:221-226
36. Czaja AJ, Carpenter HA (2004) Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. Hepatol 40:646-652
37. Cotler SJ, DeLellis R, Kaplan MM (2001) Reversibility of cirrhosis in autoimmune hepatitis with corticosteroid therapy. J Clin Gasteroenterol 32:428-430
38. Mohamadnejad M, Malekzadeh R, Nasseri-Moghaddam S, Hagh-Azali S, Rakhshani N, Tavangar SM, Sedaghat M, Alimohamadi SM (2005) Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis. Dig Dis Sci 50:547-551